INDEPENDENT NEWS

Guild to take on pharmaceutical giant GSK in court

Published: Thu 1 Apr 2010 04:35 PM
MEDIA RELEASE
1 April 2010
Guild to take on pharmaceutical giant GSK in court
The Pharmacy Guild (the Guild) will be taking multinational drug company GlaxoSmithKline (GSK) to court to get compensation for the community pharmacies that worked on the consumer level recall of Marevan (warfarin) 3mg tablets.
“Individual community pharmacists are defenceless against pharmaceutical companies like GSK,” says Annabel Young, the Guild’s CE.
On 28 January 2010, GSK asked every community pharmacy to contact all patients who had the medication dispensed since 23 November 2009.
“This was a dangerous situation for the patients affected. Community pharmacists’ primary concern is patient safety and they have an ethical and moral duty to look after their patient’s health first. They stepped up to the call and utilised their time and expertise to help swiftly resolve this serious problem.
“As frontline health care providers and medicines experts, community pharmacists deserve the respect of the pharmaceutical companies. Many of our members spent hours phoning their affected patients, giving them guidance and advice. GSK seems to think that all pharmacists do is hand over the pills – they have no appreciation for the disruption this recall caused.
“This is an important issue for our members. Many of them have spent hours on this recall and they have a reasonable expectation that their costs should be covered. GSK is not dealing with our members appropriately and they are refusing to provide any compensation for the work done.
“This is why the Guild has decided to place significant investment in this court action on behalf of all our members.”
The recall of Marevan (warfarin) 3mg tablets was the first of two medicine recalls in two months. Mylan NZ is undertaking a recall of Respigen Inhalers (salbutamol) distributed to patients between August and November 2009.
Marevan is an anti-coagulant medicine taken by patients with an increased risk of blood clotting. The recall was due to a manufacturing problem resulting in tablets potentially containing more or less warfarin than the labelled amount.
ENDS
Notes:
• The Pharmacy Guild of New Zealand (Inc) is a national membership organisation representing community pharmacy owners. We provide leadership on all issues affecting the sector and we advocate for the business interests of community pharmacy.
• For additional information on the Guild and community pharmacy please go to www.pgnz.org.nz

Next in Business, Science, and Tech

Progressive Campaigning Organisation Slams Budget 2024 - A ‘Backwards Budget Of A Thousand Cuts’
By: ActionStation
Coalition Budget Tax Switch Will Hurt Most Vulnerable
By: Tax Justice Aotearoa
Roading Investment Welcomed Amid Tough Times For Industry
By: Ia Ara Aoteara Transporting New Zealand
Budget 2024 Rail Investment Supports Reliability And Value For Money
By: KiwiRail
A Responsible Budget For The Times
By: Business New Zealand
Flybuys To Bid Farewell To New Zealanders After Nearly Three Decades
By: Loyalty New Zealand
View as: DESKTOP | MOBILE © Scoop Media